Dr. Elisabeth Aloy
Elisabeth is a Director in the Monitor Deloitte Strategy practice in Switzerland. She has 13 years of experience supporting clients in the pharma, biotech and medtech industries in EMEA. Elisabeth leads large-value transformation (product differentiation, value messaging and selling) and change projects. She advises on the strategy, design and implementation of innovative, more effective and efficient models maximising value creation and capture. She has deep expertise in various therapeutic areas including haematology, oncology, cardiology and CNS. Prior to joining Deloitte, she worked as a neuroscientist at ETH Zurich.